Company research
SpyGlass Pharma, Inc.
CIK 1778922Updated Nov 13, 2026
SecuritySGP · NASDAQ · equity
Name history
SpyGlassPharma, Inc. · through Jun 5, 2025SpyGlass Ophthalmics, Inc. · through Jan 5, 2021
SGP price & chart
Loading TradingView…
NASDAQ:SGP on TradingView ↗About the company
We are a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. Our mission is to significantly improve the lives of patients with chronic eye conditions by developing durable drug delivery solutions that can empower patients and surgeons with confidence in long-term disease control and vision preservation.
In the news
SpyGlass Pharma Appoints Shannon Treviño as General Counsel ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
Other Events
Items 8.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| AssetsUSD | 243,433,000Source | — | 258,386,000Source | — | 115,866,000Source | 23,318,000Source |
| Property, Plant and Equipment, NetUSD | 4,785,000Source | — | 2,745,000Source | — | 2,339,000Source | 2,168,000Source |
| Current assets: | ||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 223,143,000Source | — | 238,902,000Source | — | 96,358,000Source | 16,268,000Source |
| Assets, CurrentUSD | 236,461,000Source | — | 253,362,000Source | — | 108,768,000Source | 17,406,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,597,000Source | — | 1,707,000Source | — | 901,000Source | 715,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,428,000Source | — | 1,490,000Source | — | 1,552,000Source | 3,291,000Source |
| Other Assets, NoncurrentUSD | 759,000Source | — | 789,000Source | — | 492,000Source | 453,000Source |
| LIABILITIES AND EQUITY | ||||||
| LiabilitiesUSD | 11,069,000Source | — | 8,274,000Source | — | 10,166,000Source | 11,246,000Source |
| Stockholders’ equity: | ||||||
| Common Stock, Value, IssuedUSD | 0Source | — | 0Source | — | 0Source | 0Source |
| Additional Paid in CapitalUSD | 370,776,000Source | — | 368,660,000Source | — | 5,893,000Source | 4,387,000Source |
| Retained Earnings (Accumulated Deficit)USD | -138,412,000Source | — | -118,548,000Source | — | -104,730,000Source | -64,861,000Source |
| Stockholders' Equity Attributable to ParentUSD | 232,364,000Source | -78,379,000Source | 250,112,000Source | -68,852,000Source | -98,837,000Source | -60,474,000Source |
| Liabilities and EquityUSD | 243,433,000Source | — | 258,386,000Source | — | 115,866,000Source | 23,318,000Source |
| Current liabilities: | ||||||
| Liabilities, CurrentUSD | 9,437,000Source | — | 6,667,000Source | — | 8,584,000Source | 7,791,000Source |
| Operating Lease, Liability, CurrentUSD | 0Source | — | 0Source | — | 0Source | 442,000Source |
| Accounts Payable, CurrentUSD | 4,155,000Source | — | 3,514,000Source | — | 2,696,000Source | 1,978,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,632,000Source | — | 1,607,000Source | — | 1,582,000Source | 3,455,000Source |
| Preferred Stock, Value, Issued | —Source | — | —Source | — | — | — |
cash flow · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 1,675,000Source | 345,000Source | 2,786,000Source | 1,490,000Source |
| Changes in operating assets and liabilities: | ||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | 953,000Source | -372,000Source | 549,000Source | 1,339,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | -9,910,000Source | -6,530,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | -13,544,000Source | -8,201,000Source | -32,701,000Source | -22,027,000Source |
| Cash flows from investing activities: | ||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | -1,667,000Source | -164,000Source | -11,794,000Source | 22,261,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | 676,000Source | 164,000Source | 789,000Source | 1,991,000Source |
| Cash flows from financing activities: | ||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | 1,450,000Source | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | 157,755,000Source | 50,096,000Source | 124,585,000Source | 185,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | 142,544,000Source | 41,731,000Source | 80,090,000Source | 419,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 223,143,000Source | 127,235,000Source | 238,902,000Source | 57,999,000Source | 96,358,000Source | 16,268,000Source |
| Supplemental disclosure of cash flow information: | ||||||
| Income Taxes Paid, NetUSD | — | — | 0Source | 4,000Source | 1,000Source | 18,000Source |
| Additional Financial Items | ||||||
| Share-based Payment Arrangement, ExpenseUSD | 2,100,000Source | 600,000Source | 1,700,000Source | 300,000Source | 2,800,000Source | 1,500,000Source |
| DepreciationUSD | 341,000Source | 135,000Source | 318,000Source | 124,000Source | 612,000Source | 271,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 0Source | -3,900Source | 0Source | 0Source | -5,400Source | 0Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | 518,000Source | 0Source |
| General and Administrative ExpenseUSD | 11,025,000Source | 1,964,000Source | 6,867,000Source | 1,371,000Source | 12,266,000Source | 7,080,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Investment Income, InterestUSD | 2,103,000Source | 622,000Source | 1,591,000Source | 126,000Source | 3,106,000Source | 1,317,000Source |
| Net Income (Loss) Attributable to ParentUSD | -19,864,000Source | -8,675,000Source | -13,818,000Source | -8,823,000Source | -39,869,000Source | -29,164,000Source |
| Nonoperating Income (Expense)USD | 2,103,000Source | 622,000Source | 1,591,000Source | -1,400,000Source | 1,580,000Source | -2,100,000Source |
| Operating ExpensesUSD | 21,967,000Source | 9,297,000Source | 15,409,000Source | 7,423,000Source | 41,449,000Source | 27,064,000Source |
| Proceeds from Issuance of Redeemable Preferred StockUSD | — | — | 0Source | 50,010,000Source | 127,336,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 55,000Source | 100,000Source | 170,000Source | 185,000Source |
income statement · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | -21,967,000Source | -9,297,000Source | -15,409,000Source | -7,423,000Source | -41,449,000Source | -27,064,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -19,864,000Source | -8,675,000Source | -13,818,000Source | -8,823,000Source | -39,869,000Source | -29,164,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -19,864,000Source | -8,675,000Source | -13,818,000Source | -8,823,000Source | -39,869,000Source | -29,164,000Source |
| Earnings Per Share, BasicUSD per share | -0.59Source | -3.81Source | -0.69Source | -3.96Source | -17.98Source | -16.31Source |
| Earnings Per Share, DilutedUSD per share | -0.59Source | -3.81Source | -0.69Source | -3.96Source | -17.98Source | -16.31Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 33,439,543Source | 2,277,521Source | 19,927,848Source | 2,229,637Source | 2,217,104Source | 1,788,211Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 33,439,543Source | 2,277,521Source | 19,927,848Source | 2,229,637Source | 2,217,104Source | 1,788,211Source |
| Additional Financial Items | ||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | 0Source | 0Source |
| General and Administrative ExpenseUSD | 11,025,000Source | 1,964,000Source | 6,867,000Source | 1,371,000Source | 12,266,000Source | 7,080,000Source |
| Investment Income, InterestUSD | 2,103,000Source | 622,000Source | 1,591,000Source | 126,000Source | 3,106,000Source | 1,317,000Source |
| Nonoperating Income (Expense)USD | 2,103,000Source | 622,000Source | 1,591,000Source | -1,400,000Source | 1,580,000Source | -2,100,000Source |
| Operating ExpensesUSD | 21,967,000Source | 9,297,000Source | 15,409,000Source | 7,423,000Source | 41,449,000Source | 27,064,000Source |
| Research and Development ExpenseUSD | 10,942,000Source | 7,333,000Source | 8,542,000Source | 6,052,000Source | 29,183,000Source | 19,984,000Source |
Offerings
Registration 333-292779
- Gross proceeds
- 150000000.0
- Net proceeds
- 139500000.0
- Deal price
- 16.0
- Shares
- 9375000
- Offering price
- $16.00
- Ticker
- SGP
Underwriters: Name, Zach Scheiner, Ph. D., Ali Behbahani, M.D., Bilal Khan, Kirk Nielsen, Michael Dybbs, Ph. D., Robert Jake Merrill, CFA, Geoff Pardo, Elizabeth O’Farrell